Cytokines in malignant lymphomas: review and prospective evaluation - PubMed (original) (raw)
Review
Cytokines in malignant lymphomas: review and prospective evaluation
S M Hsu et al. Hum Pathol. 1993 Oct.
Abstract
Cytokines play important roles in the pathogenesis of lymphomas. Cytokines either can be produced or exert effects on neoplastic or reactive cells. The secretion of cytokines can provide growth advantages for tumor cells in either an autocrine or a paracrine fashion. An elevated serum or tissue level of cytokines can contribute to the clinical and histopathologic alterations associated with malignant lymphomas. The effects of cytokines on the histopathologic changes are most noticeable in Hodgkin's disease (HD). The malignant (Hodgkin's-Reed-Sternberg) cells in HD have been shown to secrete interleukin-1 (IL-1), IL-5, IL-6, IL-9, tumor necrosis factor-alpha, macrophage colony-stimulating factor, transforming growth factor-beta, and, less frequently, IL-4 and granulocyte colony-stimulating factor. These cytokines may be responsible for the increased cellular reaction and fibrosis observed in tissues involved by HD and for the immunosuppression in patients with HD. In contrast to Hodgkin's-Reed-Sternberg cells, most non-HD lymphoma cells do not produce cytokines in excess amounts. Exceptions include T-cell-rich B-cell lymphoma (IL-4), angioimmunoblastic lymphadenopathy-like T-cell lymphoma with plasmacytosis and hypergammaglobulinemia (IL-6), anaplastic large-cell lymphoma (IL-9), polymorphic immunocytoma (IL-6), and immunoblastic lymphoma (IBL) (IL-6). Some cytokines are involved in the unique cellular reactions in each of these types of lymphoma. For example, IL-4 is responsible for the T-cell reaction in T-cell-rich B-cell lymphoma, while IL-6 is accountable for the plasma cell reaction in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Others may be directly involved in the tumor cell growth or differentiation. For instance, IL-9 may be important for the autocrine proliferation of anaplastic large cell lymphoma, whereas IL-6 is essential for plasmacytoid differentiation in polymorphic immunocytoma. Further studies of the roles of cytokines in lymphomas may lead to major advances in the understanding of the molecular processes involved in the histopathogenesis of malignant lymphomas. Elucidation of the autocrine or paracrine function of cytokines also may lead to new approaches to a rational intervention in these disease processes.
Similar articles
- Autocrine and paracrine functions of cytokines in malignant lymphomas.
Hsu SM, Hsu PL. Hsu SM, et al. Biomed Pharmacother. 1994;48(10):433-44. doi: 10.1016/0753-3322(94)90004-3. Biomed Pharmacother. 1994. PMID: 7858153 Review. - Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
Merz H, Fliedner A, Orscheschek K, Binder T, Sebald W, Müller-Hermelink HK, Feller AC. Merz H, et al. Am J Pathol. 1991 Nov;139(5):1173-80. Am J Pathol. 1991. PMID: 1951632 Free PMC article. - [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H, Takeshita M, Krause J, Schuster K, Kikuchi M, Stutte HJ. Müller H, et al. Verh Dtsch Ges Pathol. 1992;76:164-8. Verh Dtsch Ges Pathol. 1992. PMID: 1283251 German. - [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P, Brousse N. Gaulard P, et al. Ann Pathol. 2004 Sep;24(4):330-48. doi: 10.1016/s0242-6498(04)93981-8. Ann Pathol. 2004. PMID: 15567950 Review. French.
Cited by
- Paraneoplastic dermatomyositis and Hodgkin's lymphoma in a 14-year-old girl: a case report and literature review.
Ling Y, Hu H, Xu X, Feng J, Li M, Li H, Cheng M, Wang X. Ling Y, et al. Front Oncol. 2024 Aug 7;14:1416083. doi: 10.3389/fonc.2024.1416083. eCollection 2024. Front Oncol. 2024. PMID: 39169942 Free PMC article. - Anaplastic Large Cell Lymphoma (ALCL) With a Sarcomatoid Variant Presenting As Distributive Shock in a 41-Year-Old Female: A Case Report.
Alhusari L, Abdallah M, Dakkak B, Bsiso T, Jamil M. Alhusari L, et al. Cureus. 2024 Feb 29;16(2):e55235. doi: 10.7759/cureus.55235. eCollection 2024 Feb. Cureus. 2024. PMID: 38558574 Free PMC article. - Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies.
Makgoeng SB, Bolanos RS, Jeon CY, Weiss RE, Arah OA, Breen EC, Martínez-Maza O, Hussain SK. Makgoeng SB, et al. JNCI Cancer Spectr. 2018 Dec;2(4):pky082. doi: 10.1093/jncics/pky082. Epub 2019 Mar 5. JNCI Cancer Spectr. 2018. PMID: 30873511 Free PMC article. Review. - Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma - A case report and review of the literature.
Silva WFD Junior, Pinho LLF, Farias CLG, Torres V, Costalonga EC, Filho GC, Testagrossa LA, Rocha V, Buccheri V. Silva WFD Junior, et al. Leuk Res Rep. 2018 Aug 29;10:41-43. doi: 10.1016/j.lrr.2018.07.003. eCollection 2018. Leuk Res Rep. 2018. PMID: 30225192 Free PMC article. - A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.
Vicario M, Mattiolo A, Montini B, Piano MA, Cavallari I, Amadori A, Chieco-Bianchi L, Calabrò ML. Vicario M, et al. Front Microbiol. 2018 Jun 13;9:1215. doi: 10.3389/fmicb.2018.01215. eCollection 2018. Front Microbiol. 2018. PMID: 29951044 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical